((a)) ** In general** Pursuant to the authorities and processes established under , the Director of the National Institutes of Health shall support prize competitions for one or both of the following goals:

((1)) Identifying and funding areas of biomedical science that could realize significant advancements through a prize competition.

((2)) Improving health outcomes, particularly with respect to human diseases and conditions—

((A)) for which public and private investment in research is disproportionately small relative to Federal Government expenditures on prevention and treatment activities with respect to such diseases and conditions, such that Federal expenditures on health programs would be reduced;

((B)) that are serious and represent a significant disease burden in the United States; or

((C)) for which there is potential for significant return on investment to the United States.

((b)) ** Tracking; reporting** The Director of the National Institutes of Health shall—

((1)) collect information on—

((A)) the effect of innovations funded through the prize competitions under this section in advancing biomedical science or improving health outcomes pursuant to subsection (a); and

((B)) the effect of the innovations on Federal expenditures; and

((2)) include the information collected under paragraph (1) in the triennial report under (as amended by section 2032).